196 filings
6-K
ALVO
Alvotech
11 Jun 24
Current report (foreign)
4:05pm
6-K
ALVO
Alvotech
11 Jun 24
Alvotech and STADA add to strategic alliance through denosumab partnership
8:27am
6-K
ALVO
Alvotech
7 Jun 24
Alvotech Announces Strategic Refinancing Agreement
8:35am
6-K
ALVO
Alvotech
22 May 24
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
6:30am
6-K
ALVO
Alvotech
21 May 24
Current report (foreign)
9:00am
6-K
kskdgg5
21 May 24
Current report (foreign)
8:41am
6-K
koqboe3dbmv xjgijzc
30 Apr 24
Current report (foreign)
8:00am
6-K
vtxe0c8ro1 gbw77b
25 Apr 24
Current report (foreign)
12:36pm
6-K
a28p 50hoz
19 Apr 24
Current report (foreign)
8:05am
6-K
pnd4jy2ocdx3r7js0an
16 Apr 24
Current report (foreign)
6:30pm
6-K
51r1r f4qkc6bl
22 Mar 24
Alvotech Announces Increase in Number of Own Shares
4:15pm
6-K
9925ycua3k
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
6-K
cwchhd40f 7tl
1 Mar 24
Alvotech Appoints Interim Chief Quality Officer
12:16pm
6-K
g4mbh
26 Feb 24
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
7:00am
6-K
b2pfl1iixmweggua
23 Feb 24
Current report (foreign)
8:39pm
6-K
z70o8pp
15 Feb 24
Current report (foreign)
4:00pm
6-K
1y0fs 3lw39it
29 Jan 24
Current report (foreign)
7:00am
6-K
8vbn2z41go3vid4aecas
19 Jan 24
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
4:00pm
6-K
zccxsl1g3e4iw4 h3f
10 Jan 24
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
7:00am